Santhera Pharmaceuticals Holding AG S3F-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 06/28/19 CEST
13.64UNCH (UNCH)
52 week range
0.00 - 13.64

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close13.64
  • 52 Week High13.64
  • 52 Week High Date06/28/19
  • 52 Week Low0.00
  • 52 Week Low Date-

Key Stats

  • Market Cap37.77M
  • Shares Out13.13M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close13.64
  • 52 Week High13.64
  • 52 Week High Date06/28/19
  • 52 Week Low0.00
  • 52 Week Low Date-
  • Market Cap37.77M
  • Shares Out13.13M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-1.94
  • P/E (TTM)-7.03
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Santhera Pharmaceuticals Holding AG

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Santhera Pharmaceuticals Holding AG (Santhera) is a Switzerland-based company engaged in the pharmaceutical sector. The Company is involved in the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases. The Company’s products include Catena and Raxone brands, which are primarily implemented in the symptomatic treatment of Leber's Hereditary Optic Neuropathy (LHON) diseases. Sathera Pharmaceuticals...
Elmar Schnee
Chairman
Martin Gertsch
Vice Chairman
Dario Eklund
Chief Executive Officer
Andrew Smith
Chief Financial Officer
Address
Hohenrainstrasse 24
Pratteln
4133
Switzerland